Companies: 10,795·Total market cap: $144.5T

Tsumura & Co.

Tsumura & Co.

TSMRFOTCHealthcare● Active

$28.15

+$4.95(+21.34%)

Market Cap$2.1B

P/E Ratio—

52W High$28.15

52W Low$23.2

Avg Volume54.4

Open$28.15

Beta0.06

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Tsumura & Co.（TSMRF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TSMRF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$379.57Earnings history

PE Ratio (TTM)0.1×PE Ratio deep dive

Revenue (TTM)$193.6BFull revenue history

Dividend Yield3.38%Dividend history

Shares Outstanding74.7MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Tsumura & Co. 数据

分析师预测—

营收$193.8B+7.03%

盈利EPS $378.68-11.35%

财务快照

FY 2026Revenue$193.83B▲ +7.03% YoY

202420252026

FY 2026Net Income$28.29B▼ 12.75% YoY

202420252026

FY 2026EPS$378.68▼ 11.35% YoY

202420252026

TTM:Revenue: $193.63BNet Income: $28.27BEPS: $379.57View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$28.15+21.34%$2.1B #2

$27.00+1.77%$2.0B #3

CanSino Biologics Inc.

$3.97+32.33%$1.4B #4

China Medical System Holdings Limited

$0.93-31.06%$2.3B #5

Curaleaf Holdings, Inc.

$11.51+5.40%$3.0B #6

Dermapharm Holding SE

$59.00+49.14%$2.9B

股票表现

1D+21.34%

1W+21.34%

1M+21.34%

3M+21.34%

YTD+21.34%

1Y+0.00%

5Y-18.05%

关于 Tsumura & Co.

CEOTerukazu Kato

IPO DateFeb 22, 2013

Employees4,138

CountryJP

Websitetsumura.co.jp

Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Ka…

Drug Manufacturers - Specialty & Generic HealthcareOTCJP

关于股票概览与关键数据

Tsumura & Co.（TSMRF）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Feb 22, 2013 在 OTC 上市。截至最近交易日，TSMRF 股价为 $28.15，市值约为 $2.1B。过去12个月累计回报 +0.00%，年初至今回报 +21.34%。

2026 财年 Tsumura & Co. 营收 $193.8B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Tsumura & Co.（TSMRF）股价为 $28.15，在 OTC 上市，52周区间为 $23.20 – $28.15。

TSMRF 最新股价TSMRF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议